07 December 2020 /
Our thinking
Three reasons Value could make a comeback
Schermata 2021-01-07 alle 18.22.41
Sebastien Mallet
Portfolio Manager, Global Value Equity Strategy

Three scenarios that could propel a style rotation back to value.

Key insights

  • The extreme valuation dispersion between value and growth stocks stands near historic levels. Economic recovery and improving corporate earnings are likely to benefit cyclical and value areas of the market most.
  • A coronavirus vaccine is key to unlocking short-term performance, but long term, inflation is required to deliver a more sustained rotation.
  • The narrow leadership and increasingly bifurcated nature of markets has created many opportunities for uncertainty and mispricing to be exploited.
The growth versus value style debate intensified as the dominance of “growth” accelerated during the coronavirus pandemic. Value investing has remained deeply out of favor, but we sense the dynamics are changing and the environment is now looking more favorable for value investing. When regime changes happen, they are often swift and dramatic with large stock price movements, so positioning early is important. With many investors currently not positioned for a style rotation, we examine three scenarios that could favor value investing and help investors consider their allocations.

Three factors Shaping the Year Ahead for Value

Vaccine, valuation, and greater focus on fiscal spending will favor value areas of the market

Post-Coronavirus economic recovery set to drive cyclical stock performance

We believe the global economy is currently in a mini “W‑shaped” recovery as we progress through the coronavirus pandemic. A brief recovery after the first wave has been interrupted by a resurgence in cases in the US and Europe with PMIs1 softening. However, this is likely to improve as we enter the first quarter of 2021.

Virus cases could fall, or at least become more manageable, while recent news from Pfizer and Moderna of potential vaccines, along with others in the pipeline, could accelerate our way out of this pandemic. Initial optimism is exceedingly high right now, and that could fade, but ultimately, a vaccine that works effectively will help drive economic recovery, and that would favor cyclical parts of the market.

“The world could be set for a cyclical bounce in 2021, and we are positioned for that scenario.”

China is a great example of how a recovery scenario could potentially play out globally. China has had much more success in suppressing the virus, and its economy is benefiting. Consumer spending, car sales, and economic growth have all bounced back strongly from the depths of the pandemic back in March.

Globally, some of the most sensitive sectors to the pandemic have been industrials, materials, energy, real estate, and transportation. Year‑on‑year earnings comparisons from March 2021 onward are, however, likely to look much more favorable.

New political dynamics shape a favorable fiscal and monetary backdrop

The victory of Democratic candidate Joseph Biden in the US presidential election brings with it a range of potential value‑positive policy measures. Among the possible policy actions in play are the easing of trade uncertainty (reestablishing a pillar for global growth), increased fiscal stimulus, a potentially weaker US dollar, and more substantial reflationary policies.

We expect President‑elect Biden to prioritize additional fiscal spending to stimulate the economy as it recovers from the steep downturn caused by the coronavirus pandemic. We also anticipate increased infrastructure spending alongside the possibility of higher corporate taxes. Higher taxes historically have been more detrimental to areas within the growth complex, however. 

While a Biden administration is seen as supportive of corporate tax increases, it is far from certain that these would be enacted. There are many hurdles ahead for a Biden presidency, including a split Congress and the uncertain balance of the Senate, which may dampen prospects for spending and policy changes in the near term.

Arguments for more unconventional policy to bolster economic growth have also gained traction. This includes those who favor central bank balance sheets being put to work to provide tangible income for consumers in the form of fiscal handouts. We have already seen this approach, in part, to deal with the coronavirus pandemic.

Modern Monetary Theory, which holds that governments should use fiscal policy to generate full employment, is one variation on this line of thought.

Nobody has yet demonstrated that delegating monetary policy to elected politicians will bring about better economic outcomes than the current method of allowing central banks to manage it, but helicopter money has gained traction. The gradual erosion of central bank independence means that the current environment is probably more conducive to helicopter money than it was just a few years ago.

Shifting market dynamics put focus on valuations

Value stocks have come under huge pressure as economic uncertainty has prompted investors to shorten their time horizons, pile into secular winners, and avoid cyclicals. Fear and uncertainty have also meant investors have favored well‑understood growth stories during the recovery rally without regard to valuation.

However, the market’s extreme and singular focus on secular growth and an extreme aversion to cyclical risks have contributed to the narrowing in market leadership. The FAANGs2 have become the market. This market concentration has become a concern, and we expect a broadening away from this narrow group of mega‑cap market leaders.

With the MSCI World Value Index having a meaningful overweight to financials, energy, and utilities and underweight exposure to technology and consumer discretionary—value sectors have the potential to benefit from an economic recovery and any revision to the overconcentration profile currently evident.

“Growth stocks have benefited from technological advances and recently from work‐from‐home dynamics, which have helped power cash flow and earnings.”

This is not to call a turn in the growth/value performance cycle, especially a sustainable reversion. We are also not signaling a uniform downturn for growth stocks. Indeed, many with the best growth profiles will likely continue to generate high free cash flow margins.

However, the idea that today’s biggest companies—primarily US technology companies—will continue to dominate the next decade should be viewed with caution. Seldom do the same companies, or even economies, manage to sustain such dominance.

“Economic recovery and expansionary government policy may see a potential return to a more inflationary environment, which historically has benefited value areas.”

Better times ahead

Although many of the trends driving growth outperformance may endure, we believe value stocks offer significant upside potential at this time. The maturity, narrowness, and magnitude of the current growth cycle, along with the gathering debate about the scope for a more inflationary and interventionist world, suggest that a change may be afoot. Key to unlocking short‑term performance is a coronavirus vaccine, while a more prolonged style rotation will likely need inflation.

Importantly, with valuation spreads between value and growth currently at extreme levels, a sustained regime change is not essential to see improved investment returns for value stocks. Crucially, we believe that the quality and quantity of the opportunity set available to value investors right now is as compelling as it has ever been.

ID0003753 (11/2020)


1 Purchasing managers’ indexes.

2 FAANGs: Acronym used in reference to the stocks of the five tech companies Facebook, Amazon, Apple, Netflix, and Alphabet (the G refers to Alphabet’s core company Google).

Sign up for Global Equity insights from T. Rowe Price
Share this article:
Share on linkedin
Share on email

Important Information

The specific securities identified and described are for informational purposes only and do not represent recommendations.

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested. 

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction. 

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price. 

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.

UK—This material is issued and approved by T. Rowe Price International Ltd, 60 Queen Victoria Street, London, EC4N 4TZ which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only. 

© 2021 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the bighorn sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.

Our thinking

Weekly market recap

Read Time: 10 mins Yoram …


Capital Market Insights: Are we on the cusp of a global capex boom?

Read Time: < 1 mins This …

Our thinking

The cycle – where are we? Implications for global equity investors

Read Time: 5 mins David …

Our global equity capabilities

Explore our range of funds available to 

you and your clients

Thank you for registering for global equities updates. The latest insights will be sent straight to your inbox, in the meantime see our latest thinking:

Important Legal Information

This site is intended for financial intermediaries in the United Kingdom. I have read the terms detailed below and confirm that I am a financial intermediary and that I wish to proceed. By accessing this website, you consent to T. Rowe Price collecting information by way of cookies.

Information contained in the T. Rowe Price website is not intended for investors in any jurisdiction in which distribution or purchase is not authorised, including the jurisdiction of the reader of this information, where applicable. For example, the information herein is not for distribution to and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America to or for the benefit of United States persons.

Information obtained from this site is intended specifically for the individuals who have agreed to these Terms and Conditions and may not be redistributed without prior consent from the T. Rowe Price Legal department.

The information is designed for professional investors, including financial intermediaries or members of the media, and is published for informational purposes only. In particular, the information is directed at only informing persons falling within one or more of the following categories:

(a) A government;
(b) A bank or insurance company;
(c) A pension fund or charity;
(d) Persons whose ordinary activities involve them, as principal or as agent, in acquiring, holding, managing or disposing of investments for the purposes of a business carried on by them or whom it is reasonable to expect will, acquire, manage or dispose of investments for the purpose of such a business;
(e) Persons whose ordinary business involves the giving of advice, which may lead to another person acquiring or disposing of an investment or refraining from so doing;
(f) Representatives of the media for corporate and background information about T. Rowe Price.

Persons who do not fall into one of the above categories should not act upon the information contained herein.

Certain persons may have access to information regarding the T. Rowe Price Funds SICAV, an investment company incorporated as “Société d’Investissement à Capital Variable” (‘SICAV’) under the laws of Luxembourg and the T. Rowe Price Funds OEIC, an open-ended investment company (‘OEIC’) incorporated in England and Wales. The sub-funds referred to on the site are only offered by the current prospectus. The prospectus contains more complete information about the sub-funds, including investment objectives, charges and expenses. However, the prospectus and other information relating to the sub-funds will not be intentionally distributed to persons in any country where such distribution would be contrary to local law or regulation.

Past performance is not a guide to future performance. The value of securities and any income generated from them might decrease as well as increase. Changes in rates of exchange may also have an adverse effect on the value, price or income of securities. Investors should also be aware of the additional risks associated with investments in emerging markets, high yield securities and smaller companies.

This information herein does not constitute investment advice and the products described may not be available to or suitable for all investors. You should consider, if appropriate, obtaining independent professional advice before making an investment decision.

Unless otherwise noted, the content appearing in this Section of the T. Rowe Price website has been issued by T. Rowe Price International Ltd, 60 Queen Victoria Street, London EC4N 4TZ, which is authorised and regulated by the U.K. Financial Conduct Authority with the reference number 194667.